Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.44 |
| ▸ | MAPT | P10636 | 5/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.44 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.44 |
| ▸ | KIF11 | P52732 | 1/20 | 0.43 |
| ▸ | BCHE | P06276 | 4/20 | 0.40 |
| ▸ | ACHE | P22303 | 4/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL975434 | 0.89 | GPR3 (0.44) | GPR3KDM4EMAPTALDH1A1HPGD | |
| SCHEMBL193899 | 0.88 | GPR3 (0.64) | GPR3KDM4EMAPTALDH1A1HPGD | |
| SCHEMBL29461528 | 0.80 | GPR3 (1.00) | GPR3KDM4EMAPTALDH1A1HPGD | |
| SCHEMBL29321 | 0.80 | GPR3 (1.00) | GPR3KDM4EMAPTALDH1A1HPGD | |
| Hydrochloric Acid SCHEMBL31174327 | 0.78 | GPR3 (0.94) | GPR3KDM4EMAPTALDH1A1HPGD | |
| SCHEMBL18381839 | 0.78 | GPR3 (0.94) | GPR3KDM4EMAPTALDH1A1HPGD | |
| Benzene SCHEMBL28231297 | 0.78 | GPR3 (0.94) | GPR3KDM4EMAPTALDH1A1HPGD | |
| SCHEMBL2183525 | 0.77 | KDM4E (0.41) | GPR3KDM4EMAPTALDH1A1HPGD | |
| SCHEMBL975060 | 0.76 | GPR3 (0.44) | GPR3KDM4EMAPTALDH1A1HPGD | |
| SCHEMBL9776455 | 0.76 | ALDH1A1 (0.55) | KDM4EMAPTALDH1A1HPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 298 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116554104-A | Indenone and indazolone derivatives with antioxidant activity, and synthetic method and application thereof | 西南大学 | 2023-08-08 | — | — | CN | claimed |
| CN-116143602-A | Indenone and indazolone derivatives with antioxidant activity, and synthetic method and application thereof | 西南大学 | 2023-05-23 | — | — | CN | claimed |
| US-9249244-B2 | Process for producing polydienes | BRIDGESTONE CORPORATION (JP) | 2016-02-02 | — | — | US | claimed |
| US-8652752-B2 | Sulphonium salt initiators | BASF SE (DE) | 2014-02-18 | — | — | US | claimed |
| EP-2197840-B1 | SULPHONIUM SALT INITIATORS | BASF SE (DE) | 2013-11-06 | — | — | EP | claimed |
| CN-102906093-A | Novel nk-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in nk-3 receptors mediated disorders | EUROSCREEN SA | 2013-01-30 | — | — | CN | claimed |
| US-20110166132-A1 | Gamma Secretase Modulators | AMGEN INC. (US) | 2011-07-07 | — | — | US | claimed |
| US-20100297540-A1 | SULPHONIUM SALT INITIATORS | BASF SE (DE) | 2010-11-25 | — | — | US | claimed |
| EP-2231602-A1 | GAMMA SECRETASE MODULATORS | Amgen, Inc (US) | 2010-09-29 | — | — | EP | claimed |
| EP-2197869-A1 | SULPHONIUM SALT INITIATORS | BASF SE (DE) | 2010-06-23 | — | — | EP | claimed |
| US-7671138-B2 | Polymers functionized with hydrobenzamides | BRIDGESTONE CORPORATION (JP) | 2010-03-02 | — | — | US | claimed |
| WO-2009075874-A1 | GAMMA SECRETASE MODULATORS | AMGEN INC. (US) | 2009-06-18 | — | — | WO | claimed |
| WO-2009047105-A1 | SULPHONIUM SALT INITIATORS | BASF SE (CH) | 2009-04-16 | — | — | WO | claimed |
| US-20070276122-A1 | Polymers functionalized with hydrobenzamides | BRIDGESTONE CORPORATION | 2007-11-29 | — | — | US | claimed |
| US-20070276098-A1 | Polymers functionalized with hydrobenzamide | BRIDGESTONE CORPORATION | 2007-11-29 | — | — | US | claimed |
| EP-4053095-B1 | METHOD FOR PRODUCING SODIUM SALT OF PHENOLIC COMPOUND AND BISPHOSPHITE COMPOUND | MITSUBISHI CHEM CORP (JP) | 2024-07-10 | — | — | EP | disclosed |
| CN-118251380-A | Spiro- (indan-fluorene) compounds and their use in organic electronic devices | 多蒂肯独家合成控股公司 | 2024-06-25 | — | — | CN | disclosed |
| EP-0839623-A1 | Stabiliser combination for rotomolding process | Ciba SC Holding AG (CH) | 1998-05-06 | — | — | EP | disclosed |
| CN-1177350-A | Imidazole derivatives and pharmaceutical compositions thereof | YAMANOUCHI PHARMA CO LTD (JP) | 1998-03-25 | — | — | CN | disclosed |
| US-5516920-A | POLYMER STABILIZERS | CIBA-GEIGY CORPORATION (US) | 1996-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100297540-A1 | SULPHONIUM SALT INITIATORS | SULT1A1, SULT2A1, NCOA1 | GPR3 1378/4885KDM4E 3933/4885MAPT 1627/4885 |
| US-20110166132-A1 | Gamma Secretase Modulators | BACE1, BACE2, PSEN1 | GPR3 1690/4885KDM4E 2860/4885MAPT 173/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.